Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.29 USD | -5.09% | -16.54% | -31.63% |
May. 15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
May. 15 | T2 Biosystems Shares Rise After CRG Servicing Ups Stake | MT |
Financials (USD)
Sales 2024 * | 10.5M | Sales 2025 * | 23.1M | Capitalization | 73.21M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -47M | EV / Sales 2024 * | 6.97 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
-1.16
x | P/E ratio 2025 * |
-3.06
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.09% |
Latest transcript on T2 Biosystems, Inc.
1 day | -5.09% | ||
1 week | -16.54% | ||
Current month | -16.54% | ||
1 month | +32.41% | ||
3 months | -12.09% | ||
6 months | +15.95% | ||
Current year | -31.63% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 4.29 | -5.09% | 129,086 |
24-06-06 | 4.52 | -2.59% | 434,887 |
24-06-05 | 4.64 | +2.20% | 172,779 |
24-06-04 | 4.54 | -5.02% | 91,672 |
24-06-03 | 4.78 | -7.00% | 95,691 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.63% | 73.21M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |
- Stock Market
- Equities
- TTOO Stock